3 companies
D'Ieteren Group
Market Cap: €9.4b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€177.80
7D
1.3%
1Y
-0.9%
UCB
Market Cap: €44.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€234.10
7D
1.3%
1Y
51.7%
argenx
Market Cap: €41.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€670.80
7D
0.4%
1Y
35.2%